MEN1 Foundation .org

Supporting awareness, personal research, and treatment of Multiple Endocrine Neoplasia Type 1

Pages

  • Home
  • References
  • Other resources
  • Who we are

March 4, 2020

In A 1st, Scientists Use Revolutionary Gene-Editing Tool To Edit Inside A Patient

https://www.npr.org/sections/health-shots/2020/03/04/811461486/in-a-1st-scientists-use-revolutionary-gene-editing-tool-to-edit-inside-a-patient
Posted by John F Robin No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Translate

Search this blog

Tags

acquired resistance (1) adenoma (4) adjuvant (1) AXI (1) back pain (1) berberine (1) bone mineral density (1) breast (1) breast cancer (2) Bromocriptine (4) Cabergoline (9) calcium (2) cancer (8) cannabis (1) carcinoid syndrome (1) carcinoid tumor (3) cavernous sinus (1) chemotherapy (2) chromatin (5) cisplatin (1) colon (1) CRISPR (1) cure (2) DNA (6) dopamine (4) dopamine agonist (6) DRD2 (1) drug (9) editor's notes (2) endoscopic (1) epigenetic (7) Erivedge (1) everolimus (1) fertility (1) fetus (1) forearm (1) GAS1 (1) GAS6 (1) gene (5) gene therapy (2) genetic testing (1) GEP-NETs (1) Hedgehog signaling (1) hippocampus (1) histone (8) HOT (2) hypercalcemia (2) hyperparathyroidism (8) hyperprolactinemia (5) hypocalcemia (1) hypothalamus (1) immunotherapy (1) intestine (1) intragenic deletion (1) islet cell (2) Leutetium (1) liver (1) lung (1) macroprolactin (2) macroprolactinemia (1) malignancy (2) MEN1 (7) MEN1 Foundation (2) MEN1 gene (7) menin (20) metastasis (2) methylation (7) MLL (2) MRI (3) must read (1) NETs (2) neuroendocrine (1) non-small cell lung cancer (3) nonfunctioning (1) octreotide (1) outcome (1) overview (8) pancreas (7) parathyroid (5) parathyroid hormone (3) parathyroidectomy (2) Pasireotide (1) pediatric (3) PEG (1) PHPT (2) pituitary (20) PNET (1) PRMT5 (1) prolactin (8) prolactin receptor (2) prolactinoma (9) PRRT (1) PTH (1) pulmonary (1) radiation (3) radiotherapy (2) replication (2) research (1) resistance (6) screening protocol (4) sella (1) sleep (1) staging (2) stem cells (1) sternocleidomastoid (1) suggested books (2) sunitinib (1) surgery (9) Temozolomide (3) transcription (2) transplant (1) transsphenoidal (4) treatment (34) tumor (12) tumor suppression (8) tumorigenisis (3) vinorelbine (1) virus (1) Vitamin D (2) Whipple surgery (1) women (1)

Blog Archive

  • ▼  2020 (1)
    • ▼  March (1)
      • In A 1st, Scientists Use Revolutionary Gene-Editin...
  • ►  2018 (3)
    • ►  October (2)
    • ►  August (1)
  • ►  2016 (4)
    • ►  October (1)
    • ►  February (1)
    • ►  January (2)
  • ►  2015 (2)
    • ►  February (2)
  • ►  2014 (11)
    • ►  December (1)
    • ►  November (1)
    • ►  October (1)
    • ►  September (8)
  • ►  2013 (13)
    • ►  November (1)
    • ►  September (3)
    • ►  August (2)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  January (1)
  • ►  2012 (60)
    • ►  November (2)
    • ►  October (3)
    • ►  September (3)
    • ►  August (1)
    • ►  July (1)
    • ►  June (4)
    • ►  May (33)
    • ►  March (1)
    • ►  February (4)
    • ►  January (8)

Popular Posts

  • MR-Linac Radiation Therapy: new cancer treatment technology at Froedtert Hospital, Milwaukee
    MR-Linac Radiation Therapy -One of only two sites in the U.S. offering this capability.
  • Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for MEN1?
    Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for Multiple Endocrine Neoplasia 1 (MEN-1)? T. Lassen,...
  • Chronic Inflammation and Gastroenteropancreatic Neuroendocrine Tumors
    The Association of Chronic Inflammation and Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) -Maja Cigrovski Berković, Davorka Herma...

Subscribe To

Posts
Atom
Posts
All Comments
Atom
All Comments

Followers

Total Pageviews

About Me

John F Robin
View my complete profile
Copyright 2012 MEN1 Foundation. Simple theme. Powered by Blogger.